Delayed Access to Medical Care of Patients with Breast Cancer

  • Kenia Yazmín García Perusquía Universidad Autónoma del Estado de Hidalgo
  • Juan Carlos Paz Bautista Universidad Autónoma del Estado de Hidalgo


Breast cancer is a public health problem and it is more frequent in women living in both developed and developing countries, so it is important to identify the factors associated with delayed access to health care and to implement public policies for a timely diagnosis and treatment. The objective of this review is to collect existing information on breast cancer, its definition, classification, and to identify socio-structural factors of health care services that are associated with delayed medical care that negatively affects in clinical nationalization and therefore a 5-year survival, besides the need for further research related to this topic. Timely diagnosis and therapy for patients with breast cancer require the modification and implementation of current public policies in order to contribute to the reduction of mortality, especially in developing countries, since it has not only an economic impact but also a personal, social and family impact. Late diagnosis and treatment of breast cancer have been associated with a reduced survival period due to the clinical stage of the diagnosis in which a delay of more than three months was identified related to delays in the patient and not only by the lack of identification of signs and symptoms, but also by the lack of human resources and infrastructure.


Ministerio de Salud. Subsecretaria de Salud Pública. Guías Clínicas AUGE. Cáncer de Mama. Chile: División de Prevención y Control de Enfermedades. Departamento Manejo Integral del Cáncer y otros tumores; 2015: 1-164.

Unger-Saldaña K, Infante-Castañeda C. Delay of medical care for symptomatic breast cancer: A literature review. Salud Pub. Mex. 2009; 51(suppl 2): S270-S285.

Unger-Saldaña K, Miranda A, Zarco-Espinosa G, Mainero-Ratchelous F, Bargalló-Rocha E, Miguel Lázaro-León J. Health system delay and its effect on clinical stage of breast: Multicenter study. Cancer 2015; 121: 2198-206.

Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and Mortality and Epidemiology of Breast Cancer in the World. Asian Pac. J. Cancer Prev. 2016; 17: 43-46.

Centro Nacional de Equidad de Género y Salud Reproductiva [página en internet]. México. Prevención y control de cáncer en la Mujer. Información estadística. Available from:

Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005; 10: 471-479.

Zeichner S, Terawaki H, Gogineni K. A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer. Breast Cancer (Auckl). 2016; 10: 25-36.

Kleibl Z, Kristensen V. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management. The Breast 2016; 28: 136-144.

Centro Nacional de Equidad de Género y Salud Reproductiva [homepage on the Internet]. México: Información Estadística; c 2000-2015. Available from:

Brandan ME, Villaseñor-Navarro Y. Detección del cáncer de mama: Estado de la Mamografía en México. Cancerología 2006; 1: 147-162.

Martínez M. El acceso al continuo de servicios entre niveles asistenciales en dos redes integradas de servicios de salud en Colombia: un estudio de casos múltiples de mujeres con cáncer de mama. Rev. Fac. Nac. Salud Pública 2012; 30: 86-89.

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 2010; 17: 1471-1474.

Connolly LJ, Stephen BE, Mittendorf EA, et al. Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA. Cancer. J. Clin. 2017; 67: 290-303.

American Cancer Society [homepage on the Internet] 2017. Tasas de supervivencia del cáncer de seno. Atlanta, Georgia, Estados Unidos [Last Medical Review: June 1, 2016] [Last Revised: August 18, 2016]. Available from:

Sánchez G, Niño CG, Estupiñán C. Factores asociados con el tratamiento oportuno de mujeres con cáncer de mama apoyadas por una organización no gubernamental en Bogotá. Biomédica. 2015; 35: 505-512.

Jon DE, Shaw K, Williams B, et al. The role of primary care in early detection and follow-up of cancer. Nat. Rev. Clin. Oncol. 2014; 11: 38-48.

Vahit O, Boylu S, Ok E, et al. Factors affecting breast cancer treatment delay in Turkey: a study from Turkish Federation of Breast Diseases Societies. Eur. J. Public. Health. 2015; 25: 9-14.

Unger-Saldaña K, Infante-Castañeda CB. Breast cancer delay: a grounded model of help-seeking behaviour. Soc. Sci. Med. 2011; 72: 1096-104.

Weller D, Vedsted P, Rubin G, et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br. J. Cancer 2012; 106: 1262-7.

Mignini L, Ramos S, Pesce V, et al. Demoras en el proceso de atención de pacientes con cáncer de mama en dos hospitales públicos de la provincia de Santa Fe. Rev. Argent. Salud Pública, 2016; 7: 21-26.

Khan MA, Hanif S, Igbal S, Shahzad MF, Shafique S, Khan MT. Presentation delay in breast cancer patients and its association with sociodemographic factors in North Pakistan. Chin. J. Cancer Res. 2015; 27: 288-293.
How to Cite
GARCÍA PERUSQUÍA, Kenia Yazmín; PAZ BAUTISTA, Juan Carlos. Delayed Access to Medical Care of Patients with Breast Cancer. Mexican Journal of Medical Research, [S.l.], v. 6, n. 11, jan. 2018. ISSN 2007-5235. Available at: <>. Date accessed: 22 apr. 2018. doi:

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.